It has long been speculated that resistant starch (RS) may help to prevent colorectal cancer (due to the supporting information described below). However, cancer clinical trials are exceedingly expensive, require a lot of time and are rarely done. After more than 25 years of investigations, researchers at the University of Newcastle hit the jackpot – Read More …
A huge discovery has been made by Dr. Francine Marques and her colleagues at the Baker Heart and Diabetes Institute in Australia. A new international animal study demonstrated that the lack of prebiotic fiber leads to hypertension and cardiovascular disease, (Kaye, et al. Circulation 2020). I was very happy to see that they utilized resistant Read More …
The US Food and Drug Administration just approved a Level “C” Qualified Health Claim that resistant cornstarch reduces the risk of type 2 diabetes. Click here for the link to the FDA site with this announcement. This is a huge development that happened in a quick 13 years, as the first clinical trial was published Read More …
Today, 1 out of every 3 American adults have Prediabetes with 15-30% expected to develop Type 2 Diabetes within 5 years. Without intervention, half will develop Type 2 Diabetes within 10 years. This means that the number of people with Type 2 Diabetes will be doubled or quadrupled in the near future, with disastrous consequences Read More …
The U.S. Food and Drug Administration has been evaluating a health claim petition that resistant starch from high amylose corn may help to reduce the risk of Type 2 Diabetes for more than 19 months. According to information posted on the FDA’s website, the FDA has once again extended the deadline for a decision to Read More …
Mike Keenan at Louisiana State University just published his 15th animal study with RS2 resistant starch from high amylose corn. Surprisingly, it was sponsored by Merck and examined the potential synergism between Merck’s drug Januvia® (sitagliptin) and resistant starch. Both impact GLP-1 in the gut, but by different mechanisms. Sitagliptin inhibits the breakdown of GLP-1 Read More …
Sarah Dainty just finished her Masters of Science thesis at the University of Guelph in Canada. It was called the Better Bagel Study, because they developed a bagel that contained 25 grams of resistant starch, using RS2 high amylose resistant corn starch. Participants at risk for developing type 2 diabetes consumed a bagel each day Read More …
Many studies over the year have examined the resistant starch and dietary fiber consumed in Africa. The first comparison was by Burkett and Trowell, who hypothesized that dietary fiber may be responsible for the fact that Africans have significantly reduced risk of cancer than populations eating a Westernized diet. This was called the “Fiber Gap”. Read More …